【佳學(xué)基因檢測(cè)】甲基苯巴比妥用藥指導(dǎo)基因檢測(cè)
甲苯巴比妥，5-乙基-1-甲基-5-苯基巴比妥酸，是一種巴比妥酸鹽，具有鎮(zhèn)靜、催眠和抗驚厥特性。它是一種白色、幾乎無味、無味的粉末，微溶于水和酒精。
MEBARAL®
(mephobarbital) Tablets, USP
DESCRIPTION
Mephobarbital, 5-Ethyl-1-methyl-5-phenylbarbituric acid, is a babiturate with sedative, hypnotic, and anticonvulsant properties. It occurs as a white, nearly odorless, tasteless powder and is slightly soluble in water and in alcohol.
MEBARAL (mephobarbital) is available as tablets for oral administration. The structural formula is:
 |
Inactive Ingredients: Lactose, Starch, Stearic Acid, Talc.
INDICATIONS
MEBARAL (mephobarbital) is indicated for use as a sedative for the relief of anxiety, tension, and apprehension, and as an anticonvulsant for the treatment of grand mal and petit mal epilepsy.
DOSAGE AND ADMINISTRATION
Epilepsy: Average dose for adults: 400 mg to 600 mg (6 grains to 9 grains) daily; children under 5 years: 16 mg to 32 mg (1/4 grain to ½ grain) three or four times daily; children over 5 years: 32 mg to 64 mg (½ grain to 1 grain) three or four times daily. MEBARAL (mephobarbital) is best taken at bedtime if seizures generally occur at night, and during the day if attacks are diurnal.
Treatment should be started with a small dose which is gradually increased over four or five days until the optimum dosage is determined. If the patient has been taking some other antiepileptic drug, it should be tapered off as the doses of MEBARAL (mephobarbital) are increased, to guard against the temporary marked attacks that may occur when any treatment for epilepsy is changed abruptly. Similarly, when the dose is lowered to a maintenance level or to be discontinued, the amount should be reduced gradually over four or five days.
Special Patient Population: Dosage should be reduced in the elderly or debilitated because these patients may be more sensitive to barbiturates. Dosage should be reduced for patients with impaired renal function or hepatic disease.
Combination with Other Drugs: MEBARAL (mephobarbital) may be used in combination with phenobarbital, either in the form of alternating courses or concurrently. When the two drugs are used at the same time, the dose should be about one-half the amount of each used alone. The average daily dose for an adult is from 50 mg to 100 mg (3/4 grain to 1 ½ grains) of phenobarbital and from 200 mg to 300 mg (3 grains to 4 ½ grains) of MEBARAL (mephobarbital) .
MEBARAL (mephobarbital) may also be used with phenytoin sodium; in some cases, combined therapy appears to give better results than either agent used alone, since phenytoin sodium is particularly effective for the psychomotor types of seizure but relatively ineffective for petit mal. When the drugs are employed concurrently, a reduced dose of phenytoin sodium is advisable, but the full dose of MEBARAL (mephobarbital) may be given. Satisfactory results have been obtained with an average daily dose of 230 mg (3 ½ grains) of phenytoin sodium plus about 600 mg (9 grains) of MEBARAL (mephobarbital) .
Sedation: Adults: 32 mg to 100 mg (½ grain to 1 ½ grains)–optimum dose, 50 mg (3/4 grain)–three to four times daily. Children: 16 mg to 32 mg (1/4 grain to ½ grain) three to four times daily.
HOW SUPPLIED
Tablets—white, round, convex and the 32 mg and 50 mg tablets are scored.
32 mg (½ grain), bottles of 250 (NDC 67386-801-02).
50 mg (3/4 grain), bottles of 250 (NDC 67386-802-02).
100 mg (1 ½ grains), bottles of 250 (NDC 67386-803-02).
Store at room temperature up to 25° C (77° F).
Distributed by : OVATION, Pharmaceuticals, Inc., Deerfield, I 60015, USA. Revised July 2003. FDA revision date: n/aLIDESHOW
- 【佳學(xué)基因檢測(cè)】精神分裂癥的藥物敏感性基因檢測(cè)...
- 【佳學(xué)基因檢測(cè)】抗抑郁藥物治療中如何對(duì)待用藥指導(dǎo)基因檢測(cè)結(jié)果...
- 【佳學(xué)基因檢測(cè)】CYP2C19*1/*2 和 ABCB1c.3435 CT 基因型的共存對(duì)接受氯吡格雷治療的 CAD 患者的臨床結(jié)果具有潛在影響...
- 【佳學(xué)基因檢測(cè)】使用對(duì)抗網(wǎng)絡(luò)進(jìn)行癌癥藥物反應(yīng)的正確醫(yī)學(xué)預(yù)測(cè)模型PANCDR...
- 【佳學(xué)基因檢測(cè)】氫氟噻嗪(Hydroflumethiazide)基因檢測(cè)如何提高治療效果？...
- 【佳學(xué)基因檢測(cè)】索拉非尼(Sorafenib)基因檢測(cè)如何改善治療效果？...
- 【佳學(xué)基因檢測(cè)】噻嗪類藥物(Thiazides, Plain)基因檢測(cè)及用藥指導(dǎo)是否給出應(yīng)當(dāng)換藥的說明？...
- 【佳學(xué)基因檢測(cè)】培哚普利(Perindopril)基因檢測(cè)及用藥指導(dǎo)是否給出應(yīng)當(dāng)換藥的說明？...
- 【佳學(xué)基因檢測(cè)】昔帕胺(Xipamide)基因檢測(cè)是否可以指導(dǎo)用藥劑量？...
- 【佳學(xué)基因檢測(cè)】雷米普利(Ramipril)基因檢測(cè)是否可以指導(dǎo)用藥劑量？...
- 【佳學(xué)基因檢測(cè)】螺內(nèi)酯(Spironolactone)基因檢測(cè)及用藥指導(dǎo)是否給出應(yīng)當(dāng)換藥的說明？...
- 【佳學(xué)基因檢測(cè)】螺普利(Spiropril)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】他汀類藥物(Statins)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】他克莫司(Tacrolimus)的毒副作用如何降低？...
- 【佳學(xué)基因檢測(cè)】他莫昔芬(Tamoxifen)基因檢測(cè)如何提高治療效果？...
- 【佳學(xué)基因檢測(cè)】替米沙坦(Telmisartan)基因檢測(cè)是否可以指導(dǎo)用藥劑量？...
- 【佳學(xué)基因檢測(cè)】替莫普利(Temopril)基因檢測(cè)如何改善治療效果？...
- 【佳學(xué)基因檢測(cè)】曲多拉普利(Trandolapril)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】群多普利(Trandolapril)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】纈沙坦(Valsartan)的毒副作用如何降低？...
- 【佳學(xué)基因檢測(cè)】維拉帕米(Verapamil)基因檢測(cè)如何提高治療效果？...
- 【佳學(xué)基因檢測(cè)】吲達(dá)帕胺(Indapamide)基因檢測(cè)如何改善治療效果？...
- 【佳學(xué)基因檢測(cè)】厄貝沙坦(Irbesartan)基因檢測(cè)及用藥指導(dǎo)是否給出應(yīng)當(dāng)換藥的說明？...
- 【佳學(xué)基因檢測(cè)】賴諾普利(Labetalol)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】聯(lián)合使用抗高血壓藥和利尿劑(Antihypertensives And Diuretics In Combination)基因檢測(cè)如何改善治療效果？...
- 【佳學(xué)基因檢測(cè)】阿替洛爾(Atenolol)基因檢測(cè)及用藥指導(dǎo)是否給出應(yīng)當(dāng)換藥的說明？...
- 【佳學(xué)基因檢測(cè)】阿齊沙坦(Azilsartan)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】貝那普利(Benazepril)基因檢測(cè)及用藥指導(dǎo)...
- 【佳學(xué)基因檢測(cè)】苯那普利(Benazepril)的毒副作用如何降低？...
- 【佳學(xué)基因檢測(cè)】芐氟噻嗪(Bendroflumethiazide)基因檢測(cè)如何提高治療效果？...
- 來了，就說兩句！
-
- 最新評(píng)論 進(jìn)入詳細(xì)評(píng)論頁(yè)>>
